• Molecular NameVoglibose
  • Synonymvoglibose
  • Weight267.278
  • Drugbank_IDDB04878
  • ACS_NO83480-29-9
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-3.98
  • pkaN/A
  • LogD (pH=7, predicted)-4.25
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)0.45
  • LogSw (predicted, AB/LogsW2.0)4844.74
  • Sw (mg/ml) (predicted, ACD/Labs)449.97
  • No.of HBond Donors8
  • No.of HBond Acceptors8
  • No.of Rotatable Bonds5
  • TPSA153.64
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus.
  • Absorption_valueN/A
  • Absorption (description)Slowly and poorly absorbed
  • Caco_2N/A
  • Bioavailability6.0
  • Protein binding15.0
  • Volume of distribution (VD)Low tissue affinity
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmLittle metabolism occurs and no metabolites have as yet been identified.
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A